Todd Watanabe
Vorstandsvorsitzender bei ARCUTIS BIOTHERAPEUTICS, INC.
Vermögen: 9 Mio $ am 30.04.2024
Aktive Positionen von Todd Watanabe
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.01.2016 | - |
| Vorstandsvorsitzender | 01.04.2017 | - | |
| Präsident | 01.01.2016 | - | |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Direktor/Vorstandsmitglied | 23.06.2021 | - |
Karriereverlauf von Todd Watanabe
Ehemalige bekannte Positionen von Todd Watanabe
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Kanan Therapeutics, Inc. | Geschäftsführer | 01.12.2015 | 01.02.2018 |
| Gründer | 01.12.2015 | 01.02.2018 | |
| KYTHERA BIOPHARMACEUTICALS INC | Corporate Officer/Principal | 01.10.2013 | 01.11.2015 |
Ausbildung von Todd Watanabe
| Georgetown University | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Kythera Biopharmaceuticals LLC
 Kythera Biopharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kythera Biopharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel prescription products for the aesthetic medicine market. The company was founded by Jay Edward Birnbaum, Amit D. Munshi, Nathaniel Eames David, and Keith R. Leonard, Jr. on June 3, 2004 and is headquartered in Westlake, CA. | Health Technology |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Health Technology |
| Kanan Therapeutics, Inc. |
- Börse
- Insiders
- Todd Watanabe
- Erfahrung
